Life Time's Oct. 25 nationwide fundraiser for ALS research challenges participants to work out for 90 minutes.

Although the exact causes of ALS remain unknown, both genetic and environmental factors may contribute to its development.

It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...

An AI model used seven common clinical measures of inflammation, nutritional status, and more to predict ALS prognosis, a ...

A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.

Building an online store has given columnist Kristin Neva and her husband, Todd, a project to work on together.

The Canadian amyotrophic lateral sclerosis (ALS) community is calling for the country’s government to invest CA$50 million (about $36 million) over the next five years to support the Canadian ...

A pivotal Phase 3 clinical trial testing the oral therapy pridopidine in people with amyotrophic lateral sclerosis (ALS) is expected to start in January, following promising results seen in the HEALEY ...